skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,354,455) Views

Editor in Chief Dr Roger M Pinder

1176-6328

Case report
Hyperbaric oxygen ameliorates worsening signs and symptoms of post-traumatic stress disorder
Benjamin Eovaldi, Claude Zanetti
Neuropsychiatric Disease and Treatment 2010, 6:785-789
06 December 2010

Methodology
Functional imaging of hippocampal dysfunction among persons with Alzheimer’s disease: a proof-of-concept study
David B Arciniegas, Jason R Tregellas, Donald C Rojas, et al
Neuropsychiatric Disease and Treatment 2010, 6:779-783
23 November 2010

Original Research
Neurocognitive impairment after off-pump and on-pump coronary artery bypass graft surgery – an Iranian experience
Mehdi Farhoudi, Kaveh Mehrvar, Abbas Afrasiabi, et al
Neuropsychiatric Disease and Treatment 2010, 6:775-778
19 November 2010

Review
Walking impairment in patients with multiple sclerosis: exercise training as a treatment option
Robert W Motl, Myla D Goldman, Ralph HB Benedict
Neuropsychiatric Disease and Treatment 2010, 6:767-774
16 November 2010

Review
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
Ann E Maloney, Linmarie Sikich
Neuropsychiatric Disease and Treatment 2010, 6:749-766
10 November 2010 NB


Original Research
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment 2010, 6:741-747
09 November 2010

Review
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
Jason T Lerner, Noriko Salamon, Raman Sankar
Neuropsychiatric Disease and Treatment 2010, 6:731-740
08 November 2010

Review
Update on treatment of partial onset epilepsy: role of eslicarbazepine
Markus Rauchenzauner, Gerhard Luef
Neuropsychiatric Disease and Treatment 2010, 6:723-730
02 November 2010

Case report
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine
Michele Fornaro
Neuropsychiatric Disease and Treatment 2010, 6:719-722
29 October 2010

Original Research
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
Adel Gabriel
Neuropsychiatric Disease and Treatment 2010, 6:711-717
29 October 2010

Perspectives
Could lysine supplementation prevent Alzheimer’s dementia? A novel hypothesis
Robert N Rubey
Neuropsychiatric Disease and Treatment 2010, 6:707-710
27 October 2010

Original Research
Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities
Miho Takenoshita, Tomoko Sato, Yuichi Kato, et al
Neuropsychiatric Disease and Treatment 2010, 6:699-705
13 October 2010

Review
Neuroendocrine aspects of pediatric aggression: Can hormone measures be clinically useful?
Drew H Barzman, Avni Patel, Loretta Sonnier, et al
Neuropsychiatric Disease and Treatment 2010, 6:691-697
11 October 2010

Original Research
Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia
Eric R Braverman, Amanda Lih-Chuan Chen, Thomas JH Chen, et al
Neuropsychiatric Disease and Treatment 2010, 6:681-690
15 October 2010

Review
Role of paliperidone extended-release in treatment of schizoaffective disorder
Carla M Canuso, Ibrahim Turkoz, Dong Jing Fu, et al
Neuropsychiatric Disease and Treatment 2010, 6:667-679
28 September 2010

Review
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
Samuel Frank
Neuropsychiatric Disease and Treatment 2010, 6:657-665
28 September 2010

Review
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
Mike Briley, Chantal Moret
Neuropsychiatric Disease and Treatment 2010, 6:647-655
23 September 2010

Review
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
Jessica Gresham, Lea S Eiland, Allison M Chung
Neuropsychiatric Disease and Treatment 2010, 6:639-645
22 September 2010

Original Research
Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension
Amresh Shrivastava, Megan E Johnston, Nilesh Shah, et al
Neuropsychiatric Disease and Treatment 2010, 6:633-638
22 September 2010

Original Research
Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions
Frederick Cassidy
Neuropsychiatric Disease and Treatment 2010, 6:627-631
21 September 2010

Review
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
Julie A Murphy, Jacklyn A Harris, Andrew J Crannage
Neuropsychiatric Disease and Treatment 2010, 6:619-625
22 September 2010

Review
Assessing suicidal risk with antiepileptic drugs
Marco Mula, Gail S Bell, Josemir W Sander
Neuropsychiatric Disease and Treatment 2010, 6:613-618
14 September 2010

Review
Brain amyloid β protein and memory disruption in Alzheimer’s disease
Weiming Xia
Neuropsychiatric Disease and Treatment 2010, 6:605-612
07 September 2010

Original Research
Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
Athan Spiros, Robert Carr, Hugo Geerts
Neuropsychiatric Disease and Treatment 2010, 6:589-603
06 September 2010

Case Series
Brief assessment of negative dysmorphic signs
Patrizia Fiori, Antonio Monaco, Maria Giannetti Luigi
Neuropsychiatric Disease and Treatment 2010, 6:583-587
06 September 2010

Review
Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
Rosaria Di Lorenzo, Alice Brogli
Neuropsychiatric Disease and Treatment 2010, 6:573-581
01 September 2010

Review
Once-monthly paliperidone injection for the treatment of schizophrenia
Delia Bishara
Neuropsychiatric Disease and Treatment 2010, 6:561-572
01 September 2010

Rapid Communication
Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)
Evangelia Stergiakouli, Anita Thapar
Neuropsychiatric Disease and Treatment 2010, 6:551-560
24 August 2010

Review
Management of depression in elderly stroke patients
Johan Lökk, Ahmad Delbari
Neuropsychiatric Disease and Treatment 2010, 6:539-549
26 August 2010

Original Research
Polyclonal light chains in cerebrovascular disease
Patrizia Fiori, Maria Giannetti Luigi, Linda Iurato, et al
Neuropsychiatric Disease and Treatment 2010, 6:533-537
24 August 2010

Review
Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters
Seth D Norrholm, Tanja Jovanovic
Neuropsychiatric Disease and Treatment 2010, 6:517-532
24 August 2010

Review
Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: clinical guidelines
Elizabeth Peadon, Elizabeth J Elliott
Neuropsychiatric Disease and Treatment 2010, 6:509-515
12 August 2010

Original Research
Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
Laura Gedge, Lauren Lazowski, David Murray, et al
Neuropsychiatric Disease and Treatment 2010, 6:501-508
10 August 2010

Review
Current and emerging treatment options in the management of Friedreich ataxia
Michelangelo Mancuso, Daniele Orsucci, Anna Choub, et al
Neuropsychiatric Disease and Treatment 2010, 6:491-499
30 July 2010

Review
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo®)
Paolo Solla, Antonino Cannas, Francesco Marrosu, et al
Neuropsychiatric Disease and Treatment 2010, 6:483-490
04 August 2010

Case report
Depressive and adjustment disorders – some questions about the differential diagnosis: case studies
A Presicci, P Lecce, P Ventura, et al
Neuropsychiatric Disease and Treatment 2010, 6:473-481
28 July 2010

Review
Lacosamide for the prevention of partial onset seizures in epileptic adults
Anna Kelemen, Péter Halász
Neuropsychiatric Disease and Treatment 2010, 6:465-471
28 July 2010

Review
Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
Wissam El-Hage, Simon A Surguladze
Neuropsychiatric Disease and Treatment 2010, 6:455-464
28 July 2010

Original Research
Short cognitive behavioral therapy and cognitive training for adults with ADHD – a randomized controlled pilot study
Maarit Virta, Anita Salakari, Mervi Antila, et al
Neuropsychiatric Disease and Treatment 2010, 6:443-453
16 July 2010

Review
Emerging role of sertindole in the management of schizophrenia
Stephanie L Cincotta, Joshua S Rodefer
Neuropsychiatric Disease and Treatment 2010, 6:429-441
08 July 2010

Review
Armodafinil in the treatment of sleep/wake disorders
Jonathan RL Schwartz, Thomas Roth, Chris Drake
Neuropsychiatric Disease and Treatment 2010, 6:417-427
16 July 2010

Case report
Reasons for reoperation after epilepsy surgery: a review based on a complex clinical case with three operations
José F Téllez-Zenteno, Farzad Moien-Afshari, Lizbeth Hernández-Ronquillo, et al
Neuropsychiatric Disease and Treatment 2010, 6:409-415
07 July 2010

Review
Overview of essential tremor
Theresa A Zesiewicz, Abinaya Chari, Israt Jahan, et al
Neuropsychiatric Disease and Treatment 2010, 6:401-408
07 July 2010

Original Research
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al
Neuropsychiatric Disease and Treatment 2010, 6:393-400
24 June 2010

Original Research
The dual-gate lumen model of renal monoamine transport
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment 2010, 6:387-392
05 July 2010

Original Research
Faster return to work after psychiatric consultation for sicklisted employees with common mental disorders compared to care as usual. A randomized clinical trial
Christina M van der Feltz-Cornelis, Rob Hoedeman, Fransina J de Jong, et al
Neuropsychiatric Disease and Treatment 2010, 6:375-385
05 July 2010

Evidence to Practice
Disease-modifying therapies in relapsing–remitting multiple sclerosis
Fabricio González-Andrade, José Luis Alcaraz-Alvarez
Neuropsychiatric Disease and Treatment 2010, 6:365-373
06 July 2010

Review
Getting the balance right: Established and emerging therapies for major depressive disorders
Bojana Perovic, Marija Jovanovic, Branislava Miljkovic, et al
Neuropsychiatric Disease and Treatment 2010, 6:343-364
05 July 2010

Original Research
Leiter-R versus developmental quotient for estimating cognitive function in preschoolers with pervasive developmental disorders
Claudia Portoghese, Maura Buttiglione, Andrea De Giacomo, et al
Neuropsychiatric Disease and Treatment 2010, 6:337-342
28 June 2010

Review
The role of glatiramer acetate in the early treatment of multiple sclerosis
David W Brandes
Neuropsychiatric Disease and Treatment 2010, 6:329-336
09 June 2010

Original Research
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
Michael Pennick
Neuropsychiatric Disease and Treatment 2010, 6:317-327
04 June 2010

Review
Levetiracetam as an alternative therapy for Tourette syndrome
MA Martínez-Granero, A García-Pérez, F Montañes
Neuropsychiatric Disease and Treatment 2010, 6:309-316
26 May 2010

Review
Management of refractory complex partial seizures: current state of the art
David M Treiman
Neuropsychiatric Disease and Treatment 2010, 6:297-308
26 May 2010

Rapid Communication
Abnormal auditory forward masking pattern in the brainstem response of individuals with Asperger syndrome
Johan Källstrand, Olle Olsson, Sara Fristedt Nehlstedt, et al
Neuropsychiatric Disease and Treatment 2010, 6:289-296
31 May 2010

Original Research
Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
Takahiko Nagamine
Neuropsychiatric Disease and Treatment 2010, 6:281-288
09 June 2010

Review
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
Diana Domnitei, Vishal Madaan
Neuropsychiatric Disease and Treatment 2010, 6:273-279
17 May 2010

Short Report
Structured relaxation in the treatment of akathisia: case series
Lars K Hansen, Thomas L’Allemand, Francine Thiry, et al
Neuropsychiatric Disease and Treatment 2010, 6:269-271
25 May 2010

Review
Long-acting injectable antipsychotics: focus on olanzapine pamoate
JP Lindenmayer
Neuropsychiatric Disease and Treatment 2010, 6:261-267
27 May 2010

Original Research
Trazodone effects on [3H]-paroxetine and α2-adrenoreceptors in platelets of patients with major depression

Donatella Marazziti, Giorgio Consoli, Francesca Golia, et al


Neuropsychiatric Disease and Treatment 2010, 6:255-259
10 May 2010

Review
Optimal management of Alzheimer’s disease patients: Clinical guidelines and family advice
Julia Haberstroh, Harald Hampel, Johannes Pantel
Neuropsychiatric Disease and Treatment 2010, 6:243-253
10 May 2010

Review
Current trends in drug treatment of obsessive–compulsive disorder
Eric H Decloedt, Dan J Stein
Neuropsychiatric Disease and Treatment 2010, 6:233-242
10 May 2010

Case report
Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry
Willem MA Verhoeven, Jos IM Egger, W Boudewijn Gunning, et al
Neuropsychiatric Disease and Treatment 2010, 6:227-231
03 May 2010

Case report
Neuro-Behçet’s disease: A report of sixteen patients
Radi Shahien, Abdalla Bowirrat
Neuropsychiatric Disease and Treatment 2010, 6:219-225
04 May 2010

Original Research
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management
Michele Fornaro, Matteo Martino
Neuropsychiatric Disease and Treatment 2010, 6:209-218
01 June 2010

Review
Role and rationale for the use of milnacipran in the management of fibromyalgia
Jay D Kranzler, R Michael Gendreau
Neuropsychiatric Disease and Treatment 2010, 6:197-208
30 April 2010

Review
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Steven F Werder
Neuropsychiatric Disease and Treatment 2010, 6:159-195
27 April 2010

Review
Gabapentin enacarbil – clinical efficacy in restless legs syndrome
Pinky Agarwal, Alida Griffith, Henry R Costantino, et al
Neuropsychiatric Disease and Treatment 2010, 6:151-158
22 April 2010

Review
Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
Barbara Błaszczyk, Stanisław J Czuczwar
Neuropsychiatric Disease and Treatment 2010, 6:145-150
20 April 2010

Original Research
Hypothyroidism during neonatal and perinatal period induced by thyroidectomy of the mother causes depressive-like behavior in prepubertal rats
Marisol Pineda-Reynoso, Edgar Cano-Europa, Vanessa Blas-Valdivia, et al
Neuropsychiatric Disease and Treatment 2010, 6:137-143
19 April 2010

Review
The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes
Jeff C Huffman, Christopher M Celano, James L Januzzi
Neuropsychiatric Disease and Treatment 2010, 6:123-136
05 May 2010

Case report
Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
E Ece Boylu, R Erdem Togrol, Mehmet Güney Şenol, et al
Neuropsychiatric Disease and Treatment 2010, 6:119-122
07 April 2010

Review
Clinical management of behavioral characteristics of Prader–Willi syndrome
Alan Y Ho, Anastasia Dimitropoulos
Neuropsychiatric Disease and Treatment 2010, 6:107-118
13 April 2010

Case report
Emotion recognition from stimuli in different sensory modalities in post-encephalitic patients
Yayoi Hayakawa, Masaru Mimura, Hidetomo Murakami, et al
Neuropsychiatric Disease and Treatment 2010, 6:99-105
29 March 2010

Original Research
Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
Johan Lökk
Neuropsychiatric Disease and Treatment 2010, 6:93-97
31 March 2010

Review
Psychiatric comorbidity and suicide risk in patients with chronic migraine
Maurizio Pompili, Gianluca Serafini, Daniela Di Cosimo, et al
Neuropsychiatric Disease and Treatment 2010, 6:81-91
01 April 2010

Review
Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
Jean-Pierre Olié, David Gourion, Agnès Montagne, et al
Neuropsychiatric Disease and Treatment 2010, 6:71-79
23 March 2010

Case report
Adolescent mental health: Challenges with maternal noncompliance
Vicki A Nejtek, Sarah Hardy, Scott Winter
Neuropsychiatric Disease and Treatment 2010, 6:67-69
30 March 2010

Original Research
Post-traumatic stress in patients with injury-related chronic pain participating in a multimodal pain rehabilitation program
Britt-Marie Stålnacke, Anna Östman
Neuropsychiatric Disease and Treatment 2010, 6:59-66
09 March 2010

Review
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
Izchak Kohen, Paula E Lester, Sum Lam
Neuropsychiatric Disease and Treatment 2010, 6:47-58
02 March 2010

Mini-review
Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
Jean-Michel Azorin, Charles L Bowden, Ricardo P Garay, et al
Neuropsychiatric Disease and Treatment 2010, 6:37-46
03 March 2010

Review
Role of extended release quetiapine in the management of bipolar disorders
Rayan K Al Jurdi, Lena A Dixit, Martha Sajatovic
Neuropsychiatric Disease and Treatment 2010, 6:29-35
15 February 2010

Review
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
Steffen Naegel, Mark Obermann
Neuropsychiatric Disease and Treatment 2010, 6:17-28
22 December 2009

Original Research
Impulsivity, gender, and the platelet serotonin transporter in healthy subjects
Donatella Marazziti, Stefano Baroni, Irene Masala, et al
Neuropsychiatric Disease and Treatment 2010, 6:9-15
18 December 2009

Rapid Communication
Measuring cortisol and DHEA in fingernails: A pilot study
Fay Warnock, Kevin McElwee, Rubo J Seo, et al
Neuropsychiatric Disease and Treatment 2010, 6:1-7
16 December 2009